Bioventix PLC (AIM:BVXP)

Bioventix Statistics

Total Valuation

Bioventix has a market cap or net worth of GBP 128.01 million. The enterprise value is 122.87 million.

Market Cap	128.01M
Enterprise Value	122.87M

Important Dates

The next estimated earnings date is Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	Apr 10, 2025

Share Statistics

Bioventix has 5.22 million shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	5.22M
Shares Outstanding	5.22M
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	6.11%
Owned by Institutions (%)	66.60%
Float	4.14M

Valuation Ratios

The trailing PE ratio is 16.54.

PE Ratio	16.54
Forward PE	n/a
PS Ratio	9.37
PB Ratio	11.35
P/TBV Ratio	11.35
P/FCF Ratio	17.04
P/OCF Ratio	16.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.60, with an EV/FCF ratio of 16.36.

EV / Earnings	15.66
EV / Sales	8.99
EV / EBITDA	11.60
EV / EBIT	11.72
EV / FCF	16.36

Financial Position

The company has a current ratio of 7.01

Current Ratio	7.01
Quick Ratio	6.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 69.08% and return on invested capital (ROIC) is 57.69%.

Return on Equity (ROE)	69.08%
Return on Assets (ROA)	50.09%
Return on Invested Capital (ROIC)	57.69%
Return on Capital Employed (ROCE)	92.94%
Revenue Per Employee	803,738
Profits Per Employee	461,500
Employee Count	17
Asset Turnover	1.04
Inventory Turnover	2.17

Taxes

In the past 12 months, Bioventix has paid 2.57 million in taxes.

Income Tax	2.57M
Effective Tax Rate	24.64%

Stock Price Statistics

The stock price has decreased by -37.97% in the last 52 weeks. The beta is 0.48, so Bioventix's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-37.97%
50-Day Moving Average	2,589.20
200-Day Moving Average	2,869.10
Relative Strength Index (RSI)	40.94
Average Volume (20 Days)	7,362

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioventix had revenue of GBP 13.66 million and earned 7.85 million in profits. Earnings per share was 1.48.

Revenue	13.66M
Gross Profit	12.43M
Operating Income	10.48M
Pretax Income	10.41M
Net Income	7.85M
EBITDA	10.59M
EBIT	10.48M
Earnings Per Share (EPS)	1.48

Balance Sheet

The company has 5.14 million in cash and n/a in debt, giving a net cash position of 5.14 million or 0.98 per share.

Cash & Cash Equivalents	5.14M
Total Debt	n/a
Net Cash	5.14M
Net Cash Per Share	0.98
Equity (Book Value)	11.28M
Book Value Per Share	2.16
Working Capital	10.41M

Cash Flow

In the last 12 months, operating cash flow was 7.54 million and capital expenditures -29,774, giving a free cash flow of 7.51 million.

Operating Cash Flow	7.54M
Capital Expenditures	-29,774
Free Cash Flow	7.51M
FCF Per Share	1.44

Margins

Gross margin is 90.95%, with operating and profit margins of 76.72% and 57.42%.

Gross Margin	90.95%
Operating Margin	76.72%
Pretax Margin	76.20%
Profit Margin	57.42%
EBITDA Margin	77.52%
EBIT Margin	76.72%
FCF Margin	54.97%

Dividends & Yields

This stock pays an annual dividend of 1.55, which amounts to a dividend yield of 6.33%.

Dividend Per Share	1.55
Dividend Yield	6.33%
Dividend Growth (YoY)	-0.63%
Years of Dividend Growth	1
Payout Ratio	103.12%
Buyback Yield	0.20%
Shareholder Yield	6.52%
Earnings Yield	6.13%
FCF Yield	5.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioventix has an Altman Z-Score of 81.78 and a Piotroski F-Score of 3.

Altman Z-Score	81.78
Piotroski F-Score	3